NIPPON INDIA PHARMA FUND holds 38 instruments (97.32% equity), led by Sun Pharmaceutical Industries Limited (13.31%), Lupin Limited (7.25%) and Divi's Laboratories Limited (6.52%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of NIPPON INDIA PHARMA FUND, managed by Nippon India Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 38 instruments with an equity allocation of 97.32%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
NIPPON INDIA PHARMA FUND's top 10 holdings account for 57.34% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 94.63% of net assets, spread across 2 sectors in total. Since its 30 June 2026 disclosure, the fund added 0 new positions and exited 0 positions, with Dr. Reddy's Laboratories Limited seeing the largest move (-1.67pp to 5.01%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Piramal Pharma Limited | 1.02% → 2.09% | ▲ +1.07 |
| Divi's Laboratories Limited | 5.46% → 6.52% | ▲ +1.06 |
| Sun Pharmaceutical Industries Limited | 12.78% → 13.31% | ▲ +0.53 |
| Biocon Limited | 0.68% → 0.92% | ▲ +0.24 |
| Dr. Lal Path Labs Ltd. | 1.85% → 2.05% | ▲ +0.2 |
| Sanofi India Limited | 0.87% → 1.07% | ▲ +0.2 |
| GlaxoSmithKline Pharmaceuticals Limited | 2.47% → 2.66% | ▲ +0.19 |
| Abbott India Limited | 2.09% → 2.24% | ▲ +0.15 |
| Sai Life Sciences Limited | 3.49% → 3.62% | ▲ +0.13 |
| Stock | Weight | Change |
|---|---|---|
| Dr. Reddy's Laboratories Limited | 6.68% → 5.01% | ▼ -1.67 |
| Medplus Health Services Limited | 3.18% → 2.69% | ▼ -0.49 |
| Vijaya Diagnostic Centre Limited | 2.8% → 2.42% | ▼ -0.38 |
| Mankind Pharma Limited | 4.03% → 3.74% | ▼ -0.29 |
| Syngene International Limited | 1.7% → 1.46% | ▼ -0.24 |
| Aurobindo Pharma Limited | 1.75% → 1.54% | ▼ -0.21 |
| Lupin Limited | 7.45% → 7.25% | ▼ -0.2 |
| Max Healthcare Institute Limited | 3.32% → 3.15% | ▼ -0.17 |
| Thyrocare Technologies Limited | 2.65% → 2.51% | ▼ -0.14 |
| Cipla Limited | 6.15% → 6.03% | ▼ -0.12 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Nippon India Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.